-
COST ANALYSIS OF LUPUS NEPHRITIS IN THE BRAZILIAN UNIFIED HEALTH SYSTEM - RWD STUDY
Mar 18, 2026, 21:38 PM -
UTILIZATION, EXPENDITURE, AND PRICE TRENDS FOR EZETIMIBE AND NOVEL LIPID-LOWERING MEDICATIONS IN U.S. MEDICAID DRUG UTILIZATION DATA, 2002-2024
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF PALIVIZUMAB FOR RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS IN PRETERM INFANTS IN ECUADOR
Mar 18, 2026, 21:38 PM -
CLINICIAN TESTING OF A PREFERENCE-BASED MEASURE TO TEST SENSITIVITY AND RELEVANCE FOR UTILITIES ESTIMATION IN EARLY HD
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN OF DIAGNOSED METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE (MASLD) IN US ADULTS WITH TYPE 2 DIABETES: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
LABORATORY-BASED MACHINE LEARNING ALGORITHM REDUCES UNCERTAINTY AND ENHANCES DIAGNOSTIC ACCURACY IN PERIPROSTHETIC JOINT INFECTION
Mar 18, 2026, 21:38 PM -
APPLYING TARGET TRIAL EMULATION IN VACCINE RESEARCH: METHODOLOGICAL INSIGHTS AND REGULATORY IMPLICATIONS
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN TELEHEALTH-DELIVERED NUTRITION THERAPY AND RISK OF NEW-ONSET OBESITY IN ADULTS WITH TYPE 2 DIABETES: A PROPENSITY SCORE-MATCHED SURVIVAL ANALYSIS
Mar 18, 2026, 21:38 PM -
PATIENT EXPERIENCE DOSSIERS IN PRACTICE: A DEMONSTRATION PROJECT IN METASTATIC NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
PREVALENCE RATES OF MYOTONIC DYSTROPHY TYPE 1 (DM1) IN 9 COUNTRIES: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS
Mar 18, 2026, 21:38 PM -
DIRECT ORAL ANTICOAGULANTS IN BRAZIL: PRICE TRENDS, MARKET COMPETITION, AND POLICY IMPLICATIONS
Mar 18, 2026, 21:38 PM -
FAST-TRACKED BUT FALLING SHORT? THERAPEUTIC VALUE AND POLICY ALIGNMENT OF FDA-APPROVED ANTIBIOTICS, 2010-2025
Mar 18, 2026, 21:38 PM -
PREVALENCE AND SEVERITY OF ACNE VULGARIS IN FEMALE UNIVERSITY STUDENT ASSESSED FOR PCOS RISK
Mar 18, 2026, 21:38 PM -
U.S. REAL-WORLD PRESCRIBING PATTERNS OF MIXED GONADOTROPIN OVARIAN STIMULATION PROTOCOLS: A CLAIMS-BASED ANALYSIS
Mar 18, 2026, 21:38 PM -
SOCIOECONOMIC BURDEN OF DRY EYE DISEASE IN THE UNITED STATES: REAL-WORLD EVIDENCE FROM THE ADELPHI DED DISEASE SPECIFIC PROGRAMME
Mar 18, 2026, 21:38 PM -
EVALUATION OF AI-ASSISTED MULTI-ROW DATA EXTRACTION FOR META-ANALYSIS USING EASYSLR
Mar 18, 2026, 21:38 PM -
COMPARATIVE ANALYSIS OF RISK FACTORS AND SHORT-TERM OUTCOMES AFTER PRIMARY PCI IN PRE- AND POST-MENOPAUSAL WOMEN WITH STEMI EXPERIENCE FROM LMIC
Mar 18, 2026, 21:38 PM -
A UNITED STATES BUDGET IMPACT ANALYSIS OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN THE TREATMENT OF INADEQUATELY CONTROLLED ASTHMA
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF EARLY DIAGNOSIS AND TREATMENT FOR INBORN ERRORS OF IMMUNITY WITH A FOCUS ON COMMON VARIABLE IMMUNODEFICIENCY (CVID) IN SPAIN: A COST-EFFECTIVENESS PERSPECTIVE
Mar 18, 2026, 21:38 PM -
ESTIMATING STATE- AND COUNTY-LEVEL CHRONIC DISEASE AND RISK FACTOR PREVALENCE: VALIDATING A SYNTHETIC POPULATION APPROACH USING NATIONALLY REPRESENTATIVE SURVEY DATA
Mar 18, 2026, 21:38 PM
